Indaptus Therapeutics, Inc. ( INDP) - Key Metrics
INDP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.02 | -$0.02 | -$0.02 |
| 2026Q1 | $0 | -$1.17 | -$3.23 | -$3.23 |
| 2025Q4 | $0 | -$3.74 | -$1.47 | -$1.47 |
| 2025Q3 | $0 | -$0.52 | -$0.53 | -$0.53 |
| 2025Q2 | $0 | -$0.91 | -$0.70 | -$0.70 |
INDP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -48.39 |
| 2026Q1 | 0% | -0.39 |
| 2025Q4 | 0% | -0.19 |
| 2025Q3 | 0% | -1.38 |
| 2025Q2 | 0% | -2.89 |
INDP
Price: $2.77
52 week price:
Earnings Per Share: -3.36 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 19752
Market Capitalization: 138.2 million